Announcements Trials
Browse Landscape

Phase

Phase 3 14Phase 2 14Phase 1 8Phase 2/3 5Phase 1/2 2Phase NA 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Standard of Care 23Specimen Handling 20Practice Guidelines as Topic 17Interviews as Topic 17Methods 15Educational Status 15Early Intervention, Educational 14Exercise 13Blood Specimen Collection 11Magnetic Resonance Spectroscopy 10Surveys and Questionnaires 8Patient Navigation 8Radiosurgery 7Palliative Care 7Radiotherapy 6Counseling 6Surgical Procedures, Operative 5Resistance Training 5Nutrition Assessment 5X-Rays 4Therapeutics 4Health Promotion 4Diet Therapy 4Biopsy 4Acupressure 4Robotic Surgical Procedures 3Radiation Dose Hypofractionation 3Radiation 3Positron-Emission Tomography 3Paclitaxel 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Platinum × 30 days × Clear all
NCT02194738 2026-05-29

Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

National Cancer Institute (NCI)

Phase NA Active not recruiting
8,300 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡